Abnormalities, Drug-Induced
"Abnormalities, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
Descriptor ID |
D000014
|
MeSH Number(s) |
C16.131.042
|
Concept/Terms |
Abnormalities, Drug-Induced- Abnormalities, Drug-Induced
- Abnormalities, Drug Induced
- Drug-Induced Abnormalities
- Abnormality, Drug-Induced
- Drug Induced Abnormalities
- Drug-Induced Abnormality
|
Below are MeSH descriptors whose meaning is more general than "Abnormalities, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Abnormalities, Drug-Induced".
This graph shows the total number of publications written about "Abnormalities, Drug-Induced" by people in this website by year, and whether "Abnormalities, Drug-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 | 2006 | 0 | 1 | 1 | 2007 | 1 | 0 | 1 | 2008 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Abnormalities, Drug-Induced" by people in Profiles.
-
Cooper AM, Horwitz M, Becker ML. Improving the Safety of Teratogen Prescribing Practices in a Pediatric Rheumatology Clinic. Pediatrics. 2019 04; 143(4).
-
Stancil SL, Miller M, Briggs H, Lynch D, Goggin K, Kearns G. Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications. Pediatrics. 2016 Jan; 137(1).
-
Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2008 Mar; 82(3):155-65.
-
Leeder JS, Mitchell AA. Application of pharmacogenomic strategies to the study of drug-induced birth defects. Clin Pharmacol Ther. 2007 Apr; 81(4):595-9.
-
Crowley AR, Mehta SS, Hembree MJ, Preuett BL, Prasadan KL, Sharp SW, Yew H, McFall CR, Benjes CL, Tulachan SS, Gittes GK, Snyder CL. Faulty bone morphogenetic protein signaling in esophageal atresia with tracheoesophageal fistula. J Pediatr Surg. 2006 Jul; 41(7):1208-13.
-
Spilde TL, Bhatia AM, Marosky JK, Preuett B, Kobayashi H, Hembree MJ, Prasadan K, Daume E, Snyder CL, Gittes GK. Fibroblast growth factor signaling in the developing tracheoesophageal fistula. J Pediatr Surg. 2003 Mar; 38(3):474-7; discussion 474-7.
-
Leeder JS, Spielberg SP, MacLeod SM. Bendectin: the wrong way to regulate drug availability. Can Med Assoc J. 1983 Nov 15; 129(10):1085-7.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|